FCM
PTLA

Farallon Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Farallon Capital Management’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-250,000
Closed -$14M – 97
2017
Q2 		$14M Buy
+250,000
New +$10M 0.15% 61

Farallon Capital Management's PTLA Position: Q3 2020 in Review

Farallon Capital Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 1,844,757 shares — an estimated $33.2M sold.

Farallon Capital Management first reported a position in PTLA in Q4 2016 and held it in 4 quarters. The position peaked at $48M in Q2 2017. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • Farallon Capital Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Farallon Capital Management sold 1,844,757 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $33.2M.
  • Farallon Capital Management first reported a position in Portola Pharmaceuticals, Inc. in Q4 2016 and held it in 4 quarters.
  • Farallon Capital Management's Portola Pharmaceuticals, Inc. position peaked at $48M in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Farallon Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.